I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 7 studies | 23% ± 10% | |
| natural killer cell | 6 studies | 20% ± 3% | |
| epithelial cell | 6 studies | 35% ± 18% | |
| non-classical monocyte | 4 studies | 31% ± 10% | |
| B cell | 4 studies | 21% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 17% ± 3% | |
| CD4-positive, alpha-beta T cell | 4 studies | 23% ± 6% | |
| CD8-positive, alpha-beta T cell | 4 studies | 20% ± 1% | |
| conventional dendritic cell | 4 studies | 32% ± 17% | |
| endothelial cell | 4 studies | 22% ± 4% | |
| fibroblast | 4 studies | 20% ± 6% | |
| ciliated cell | 4 studies | 33% ± 14% | |
| dendritic cell | 4 studies | 35% ± 20% | |
| basal cell | 4 studies | 28% ± 14% | |
| naive B cell | 3 studies | 17% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 2% | |
| macrophage | 3 studies | 23% ± 4% | |
| plasmacytoid dendritic cell | 3 studies | 24% ± 4% | |
| regulatory T cell | 3 studies | 18% ± 2% |
